• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • TheStreet Smarts
  1. Home
  2. / Investing
  3. / Healthcare

Boston Scientific's Wicked Rally Can Take the Stock 20% Higher

BSX has rallied the past nine months.
By BRUCE KAMICH
Mar 21, 2023 | 02:59 PM EDT

Boston Scientific (BSX) made a new 52-week high on Tuesday. Can this advance keep going?

Let's check the position of the charts and the condition of the indicators.

In the daily bar chart of BSX, below, I can see that share prices made a low back in June. BSX has rallied the past nine months and trades above the rising 50-day moving average line and above the rising 200-day line.

The On-Balance-Volume (OBV) line shows a rise from October and tells me that traders are being more aggressive buyers of BSX. The Moving Average Convergence Divergence (MACD) oscillator is in a bullish alignment above the zero line.

 
In the weekly Japanese candlestick chart of BSX, below, I see a mostly bullish picture. Prices are in a longer-term uptrend and trade above the rising 40-week moving average line.
 
The weekly OBV line shows strength from September and helps to confirm the price gains. The MACD oscillator is well above the zero line but the two moving average lines that make up this indicator have narrowed sharply. This condition can mean a turn up or down in the indicator could come quickly.
 
 
In this daily Point and Figure chart of BSX, below, I can see that prices just made a new high for the move up and refreshed the uptrend. A price target in the $59 area is shown.
 
 
 
 
In this weekly Point and Figure chart of BSX, below, I can see the same price target of $59 as shown on the daily chart above.
 
 
Bottom-line strategy: Unless dragged down by weakness in the broader market averages, I would look for shares of BSX to continue to trade higher. The $59 area is my next price target.
 
Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

Employees of theStreet are prohibited from trading individual securities.

TAGS: Investing | Technical Analysis | Healthcare | Life Sciences | Technology Hardware & Equipment

More from Healthcare

An Update on My Top Small-Cap Pick and What It Means for the Overall Market

James "Rev Shark" DePorre
Sep 26, 2023 11:30 AM EDT

The good news is that the corrective action is advancing and opportunities are developing.

Moderna's Chart Messages Are Frustrating the Bulls

Bruce Kamich
Sep 19, 2023 9:20 AM EDT

The technical indicators suggest that traders should wait until a bottom pattern plays out in the shares of the vaccine maker.

This Biotech Stock Pick Is Just Starting to Make Beautiful Music

Bret Jensen
Sep 15, 2023 9:00 AM EDT

Things have started to turn up for this midcap name. Look for these shares to end the year on an up note.

UnitedHealth Shares Are Not Looking All That Healthy

Bruce Kamich
Sep 14, 2023 11:05 AM EDT

Let's take the temperature of this important Dow component.

Moderna: Is It Time to Take a Shot?

Bruce Kamich
Sep 13, 2023 12:52 PM EDT

Let's review the trends, charts and indicators.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 12:13 PM EDT BRUCE KAMICH

    8 Trading Rules from T. T. Hoyne

    You just read the header for this missive and prob...
  • 08:42 AM EDT JAMES "REV SHARK" DEPORRE

    This Weekend on Real Money

    How Elite Traders Make Big Profits
  • 02:58 PM EDT BRUCE KAMICH

    Classic Trading Rules From Bernard Baruch

    Bernard Baruch listed the rules (below) in his aut...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2023 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login